AgeX Therapeutics, Inc. — Form D
AgeX Therapeutics, Inc. of ALAMEDA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-21. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-06-21
- Form: D
- Accession: 0001462573-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2018-06-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-315096
Issuer
- Name: AgeX Therapeutics, Inc.
- CIK: 0001708599
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1010 ATLANTIC AVENUE, ALAMEDA, CA, 94501
- Phone: 510-521-3390
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Alfred D Kingsley | Director | Irvine, CA |
| Alfred D Kingsley | Executive Officer | Irvine, CA |
| Annalisa F Jenkins | Director | Alameda, CA |
| John F Mauldin | Director | Alameda, CA |
| Gregory D Bailey | Director | Alameda, CA |
| Not Applicable H BioTime, Inc. | Promoter | Alameda, CA |
| Michael H Mulroy | Director | Alameda, CA |
| Russell D Skibsted | Executive Officer | Alameda, CA |
| John H Mauldin | Director | Alameda, CA |
| Michael D West | Director | Menlo Park, CA |
| Michael D West | Executive Officer | Menlo Park, CA |
Other filings by this issuer (4)
More